Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
My overall experience at Karyopharm has been good. As an organization, we've come far and it is my belief we will go even further with our new leadership team. We will continue working hard to make a difference in the lives of patients and their families.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
The open-door policy and inclusiveness
Quelle est la meilleure partie de votre programme de rémunération?
The level of coverage received
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
We have a healthy and open communication culture at Karyopharm.
Qu’est-ce qui vous rend le plus heureux au travail?
I'm most happy working with others I can learn from who exhibit their appreciation for my contributions regularly.
Quelles sont les meilleures choses à propos de votre équipe?
We work tremendously well in a collaborative and supportive manner. We successfully meet identified goals and have a good time during the process.
Other Employee Reviews for Karyopharm Therapeutics
×